By Adedamola Agboola, blackenterprise.com
George Njoroge, Ph.D., has been awarded over 100 patents for his work in cancer and immunology research and discovery. Although all of Njoroge’s patents and accomplishments were all in the United States, a quick search online reveals media coverage largely from African publishers. This weekend the scientist will be honored with the Pioneer Award for Impact in Science and Medicine at Face2Face Africa’s FACE List Awards.
With over 30 years of experience in research, Njoroge is currently a senior research fellow at global pharmaceutical corporation Lilly. He was formerly a director in the Department of Medicinal Chemistry at Merck Research Laboratories where he oversaw chemistry program in infectious diseases platform. Through research leadership at Merck, an anti-HCV viral drug Victrelis™ (also known as Boceprevir or SCH 503034) was discovered. This medicine was approved by the FDA on May 13, 2011, as the first-in-class therapy for Hepatitis C treatment and is currently in the market.
Set to begin Thursday, July 12 at the Metropolitan West, the weekend kicks off with the Pan-African Women’s Forum (PAWF), which is in its second year. PAWF will provide the platform for attendees to engage and network with groundbreaking and industrious women.